Hysingla ER 40 MG tablet 60S
Ended Awarded
- Contract number
- SPE2DB25FVLH1
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $2,844
Award facts
- Contract value 100% obligated
- $2,843.74 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $2,843.74 delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Hysingla ER 40 mg tablets (60-count). This contract represents a firm fixed price, competitively awarded delivery order with no set-aside designation and an ultimate completion date of September 16, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is executed as a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a ceiling value of $999,999,999.00 and extends through December 2026.
AmerisourceBergen Drug Corp serves as a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems through the Defense Logistics Agency. The company's substantial IDC vehicle enables the supply of a comprehensive range of pharmaceutical products and medical supplies to support defense health operations globally. This specific delivery order for Hysingla ER, an extended-release opioid pain management medication, reflects the company's role in fulfilling specialized pharmaceutical requirements across the Department of Defense medical supply chain. The award was competitively determined and demonstrates AmerisourceBergen's continued capability to meet federal healthcare procurement standards.
Quick answers
Who was awarded contract SPE2DB25FVLH1?
SPE2DB25FVLH1 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 15, 2025.
How much is contract SPE2DB25FVLH1 worth?
The government has obligated $2,844 on SPE2DB25FVLH1.
Is contract SPE2DB25FVLH1 an order under another contract?
Yes. SPE2DB25FVLH1 is a delivery order under SPE2DB22D1202, an indefinite delivery contract.
Was contract SPE2DB25FVLH1 competed?
The extent of competition for SPE2DB25FVLH1 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award